Jul 14, 2020
Neuronetics Announces the Appointment of Keith J. Sullivan as President and Chief Executive Officer
Oct 21, 2019
Neuronetics CEO Chris Thatcher to Ring Nasdaq Closing Bell on October 22 in Honor of National Depression Awareness Month
Oct 03, 2019
Neuronetics® Unveils Promising New Depression Research Data at Psych Congress
Sep 04, 2019
Neuronetics® Announces Greenbrook® TMS Installation Milestone for NeuroStar® Advanced Therapy System
Aug 19, 2019
Researchers at USU Unveil Neuronetics®-supported Clinical Research for PTSD and Traumatic Brain Injury at the Military Health System Research Symposium
Aug 01, 2019
Neuronetics® Announces First TMS Patient Treated Under New Japan Reimbursement Policy
Jul 29, 2019
Neuronetics® Launches TrakStar® Plus Patient Data Management System to Maximize Physician Time with Patients
May 14, 2019
NeuroStar® Advanced Therapy Survey Finds Majority of Americans Don't Feel Very Equipped to Discuss Depression With Loved Ones
Mar 21, 2019
Neuronetics, Inc. Celebrates Dr. Charles Epstein's Contributions to Magnetic Stimulation Research
Nov 13, 2018
NeuroStar® Advanced Therapy and Transformations TMS Expanding Partnership to Increase Patient Access to Depression Treatment
Oct 16, 2017
Neuronetics, Inc. Partners with Teijin Pharma Limited, a Leading Healthcare Company in Japan, to Distribute NeuroStar Advanced Therapy
Oct 11, 2017
NeuroStar® Advanced Therapy Approved as a Life-Changing Depression Treatment to Help Conquer Depression in Japan